Efficacy and Safety of Trabectedin or Dacarbazine in Patients with Advanced Uterine Leiomyosarcoma after Failure of Anthracycline-based Chemotherapy: Subgroup Analysis of a Phase 3, Randomized Clinical Trial

OBJECTIVE: Trabectedin demonstrated significantly improved disease control in leiomyosarcoma and liposarcoma patients in a global phase 3 trial (NCT01343277). A post hoc analysis was conducted to assess the efficacy and safety of trabectedin or dacarbazine in women with uterine leiomyosarcoma (uLMS)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gynecol Oncol
Main Authors: Hensley, Martee L., Patel, Shreyaskumar R., von Mehren, Margaret, Ganjoo, Kristen, Jones, Robin L., Staddon, Arthur, Rushing, Daniel, Milhem, Mohammed, Monk, Bradley, Wang, George, McCarthy, Sharon, Knoblauch, Roland E., Parekh, Trilok V., Maki, Robert G., Demetri, George D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5783302/
https://ncbi.nlm.nih.gov/pubmed/28651804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2017.06.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados